EUFLEXXA (1% SODIUM HYALURONATE)
FDA premarket approval P010029/S023 · decided 2015-04-02
Approval details
- PMA number
- P010029
- Supplement
- S023
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- EUFLEXXA (1% SODIUM HYALURONATE)
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Ferring Pharmaceuticals, Inc.
- Date received
- 2015-03-06
- Decision date
- 2015-04-02
- Days to decision
- 27 days
- Decision code
- OK30
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Parsippany, NJ
- Statement
- INCREASE IN THE PURIFICATION CAPACITY OF AN INTERMEDIATE USED IN THE MANUFACTURE OF THE EUFLEXXA PRODUCT.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.